Impact of Time from Referral to Treatment on Outcomes and Cost of Therapy for Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma: An Intention to Treat Analysis

被引：0
|
作者：
Patel, Vivek [1 ]
Baker, Katherine [1 ]
Fishman, Danielle [1 ]
Lessans, Spencer [1 ]
Morris, Trent [1 ]
Dholaria, Bhagirathbhai [1 ]
Jayani, Reena [1 ]
Kassim, Adetola A. [1 ]
Kim, Tae Kon [1 ]
Morgan, David [1 ]
Oluwole, Olalekan O. [1 ]
Savani, Bipin N. [1 ]
Sengsayadeth, Salyka M. [1 ]
Bhaskar, Shakthi [1 ]
机构：
[1] Vanderbilt Univ, Div Hematol Oncol, Med Ctr, Nashville, TN USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-189084
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy
    Iacoboni, Gloria
    Iraola-Truchuelo, Josu
    O'Reilly, Maeve
    Navarro, Victor
    Menne, Tobias
    Kwon, Mi
    Martin-Lopez, Ana africa
    Chaganti, Sridhar
    Delgado, Javier
    Roddie, Claire
    Perez, Ariadna
    Norman, Jane
    Guerreiro, Manuel
    Gibb, Adam
    Caballero, Ana Carolina
    Besley, Caroline
    Martinez-Cibrian, Nuria
    Mussetti, Alberto
    Sanderson, Robin
    Luzardo, Hugo
    Iyengar, Sunil
    Sanchez, Jose Maria
    Jones, Ceri
    Sancho, Juan-Manuel
    Barba, Pere
    Latif, Anne-Louise
    Lopez-Corral, Lucia
    Hernani, Rafael
    Reguera, Juan Luis
    Sureda, Anna
    Garcia-Sancho, Alejandro Martin
    Bastos, Mariana
    Abrisqueta, Pau
    Kuhnl, Andrea
    HEMASPHERE, 2024, 8 (05):
  • [2] Cytomegalovirus impact in b-cell lymphoma patients treated with chimeric antigen receptor t-cell therapy
    Marquez-Algaba, E.
    Pernas, B.
    Esperalba, J.
    Los-Arcos, I.
    Carpio, C.
    Iacoboni, G.
    Barba, P.
    Ruiz-Camps, I.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 134 - 134
  • [3] Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy
    Voltin, Conrad-Amadeus
    Godel, Philipp
    Beckmann, Laura
    Heger, Jan-Michel
    Kobe, Carsten
    Kutsch, Nadine
    Borchmann, Peter
    Dietlein, Markus
    Herrmann, Ken
    Stelljes, Matthias
    Rahbar, Kambiz
    Lenz, Georg
    Reinhardt, H. Christian
    Teichert, Marcel
    Noppeney, Richard
    Albring, Jorn C.
    Seifert, Robert
    von Tresckow, Bastian
    Flossdorf, Sarah
    Hanoun, Christine
    HEMASPHERE, 2023, 7 (01): : E817
  • [4] Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma
    Hamilton, Mark P.
    Miklos, David B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1053 - 1075
  • [5] Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma
    Zhou, Wenyujing
    Chen, Weihong
    Wan, Xiaochun
    Luo, Changru
    Du, Xin
    Li, Xiaoqing
    Chen, Qian
    Gao, Ruiwen
    Zhang, Xiaohan
    Xie, Mei
    Wang, Mingjun
    FRONTIERS IN GENETICS, 2022, 12
  • [6] Defining 'Intention' in intention-to-treat survival outcomes for chimeric antigen receptor T-cell therapy
    Milrod, Charles J.
    Steuer, Rebecca
    Pelcovits, Ari
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [7] Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes
    Bourlon, Christianne
    Roddie, Claire
    Menne, Tobias
    Norman, Jane
    O'Reilly, Maeve
    Gibb, Adam
    Besley, Caroline
    Chaganti, Sridhar
    Arias, Carlos Gonzalez
    Jones, Ceri
    Dikair, Abdalla
    Allen, Sharon
    Seymour, Frances
    Osborne, Wendy
    Mathew, Amrith
    Townsend, William
    Patten, Piers E. M.
    Thoulouli, Eleni
    Abdulgawad, Ahmed
    Lugthart, Sanne
    Sanderson, Robin
    Kirkwood, Amy A.
    Kuhnl, Andrea
    HAEMATOLOGICA, 2024, 109 (08) : 2716 - 2720
  • [8] Impact of Extranodal Involvement on Outcomes with Chimeric Antigen Receptor T-Cell Therapy in B-Cell Non-Hodgkin Lymphoma
    Kumar, Vinod
    Alotaibi, Shaykhah
    Li, Zhuo
    Ayala, Ernesto
    Kharfan-Dabaja, Mohamed A.
    Iqbal, Madiha
    BLOOD, 2024, 144 : 5129 - 5130
  • [9] Healthcare Utilization and Costs in Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma
    Denlinger, Nathan
    Huang, Ying
    Braunstein, Zachary
    Sigmund, Audrey
    Bajwa, Amneet
    Kapoor, Nilesh
    Agyeman, Akwasi
    Fisher, Scott
    Purdin, Zebulun
    Neal, Alison
    Yucebay, Filiz
    Roddy, Julianna
    Brammer, Jonathan
    William, Basem
    Saad, Ayman
    Penza, Sam
    Voorhees, Timothy
    Kittai, Adam
    de Lima, Marcos
    Vasu, Sumithira
    Jaglowski, Samantha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S381 - S382
  • [10] Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
    Strati, Paolo
    Ahmed, Sairah
    Furqan, Fateeha
    Fayad, Luis E.
    Lee, Hun J.
    Iyer, Swaminathan P.
    Nair, Ranjit
    Nastoupil, Loretta J.
    Parmar, Simrit
    Rodriguez, Maria A.
    Samaniego, Felipe
    Steiner, Raphael E.
    Wang, Michael
    Pinnix, Chelsea C.
    Horowitz, Sandra B.
    Feng, Lei
    Sun, Ryan
    Claussen, Catherine M.
    Hawkins, Misha C.
    Johnson, Nicole A.
    Singh, Prachee
    Mistry, Haleigh
    Johncy, Swapna
    Adkins, Sherry
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Green, Michael R.
    Flowers, Christopher R.
    Westin, Jason
    Neelapu, Sattva S.
    BLOOD, 2021, 137 (23) : 3272 - 3276
12345